Research and Markets (http://www.researchandmarkets.com/research/6c2429/alliance_pharma_pl)
has announced the addition of the Alliance
Pharma plc-Detailed Product Pipeline company profile to their
offering.
Alliance Pharma plc - Detailed Product Pipeline report contains detailed
information on pipelines by phase and therapeutic indication as well as
management information,deals and alliances and recent news on the
company including key milestones.
Scope of the reports:
This Pipeline Report provides the user with real detail on a companys
pipeline.
In addition to business summaries, contact information, company details
and selected financial data, each report also contains extensive
information in tabular and graphical formats on a companys product
pipeline and disease hub classification.
Product details consist of complete descriptions, therapeutic
indication, drug class, mechanism of action and clinical trial
information. Every report also includes detail on a companys deals and
alliances and recent corporate news including key milestones.
Key Benefits:
Understand a companys strategic position by accessing detailed
independent intelligence on its product pipeline.
Keep track of your competitors and partners by better understanding
their product pipeline.
Monitor a companys research effectiveness by determining pipeline
depth and numbers of products in development by clinical phase.
Key Topics Covered:
Business Summary
Financials
Product Glance
-Products by Phase of Development
-Products by Disease Hub Classification
-Products by Indication
Company Sales Figures
-Product Revenue
Product Summary
Product Details
Recent Updates
For more information visit http://www.researchandmarkets.com/research/6c2429/alliance_pharma_pl
Source: Life Science Analytics
Source: Business Wire